Thomas Seeholzer
Impact in
-
- NF-κB Signaling Pathways
-
- Immune Cell Function and Interaction
- Immune Response and Inflammation
- interferon and immune responses
Papers in
-
- T-cell and B-cell Immunology 3
- Immune Response and Inflammation 2
- Immunotherapy and Immune Responses 2
- interferon and immune responses 2
-
- Ubiquitin and proteasome pathways 2
- Co-authors
- Daniel Krappmann (13 shared papers)Torben Gehring (6 shared papers)Jürgen Ruland (2 shared papers)Katja Lammens (2 shared papers)Andreas Gewies (2 shared papers)Thomas Brocker (1 shared paper)Ute Greczmiel (1 shared paper)Isabel Meininger (1 shared paper)
- Journals
- Frontiers in Immunology (3 papers)Antibiotics (2 papers)Nature Communications (2 papers)Science Signaling (1 paper)Journal of the European Academy of Dermatology and Venereology (1 paper)
- Partner nations
- GermanyEthiopiaUnited States
In The Last Decade
Thomas Seeholzer
17 papers receiving 377 citations
Peers
Comparison fields: 5 of 63
- Cancer Research 121
- Immunology 170
- Applied Microbiology and Biotechnology 7
- Molecular Medicine 18
- Oncology 76
Countries citing papers authored by Thomas Seeholzer
This map shows the geographic impact of Thomas Seeholzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Seeholzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Seeholzer more than expected).
Fields of papers citing papers by Thomas Seeholzer
This network shows the impact of papers produced by Thomas Seeholzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Seeholzer. The network helps show where Thomas Seeholzer may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Seeholzer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 83 | |
| 2 | 2023 | 51 | |
| 3 | 2018 | 49 | |
| 4 | 2018 | 44 | |
| 5 | 2016 | 39 | |
| 6 | 2022 | 18 | |
| 7 | 2022 | 16 | |
| 8 | 2018 | 12 | |
| 9 | 2024 | 11 | |
| 10 | 2023 | 11 | |
| 11 | 2020 | 11 | |
| 12 | 2018 | 9 | |
| 13 | 2024 | 8 | |
| 14 | 2024 | 7 | |
| 15 | 2022 | 5 | |
| 16 | 2023 | 4 | |
| 17 | 2025 | 1 | |
| 18 | 2025 | 0 |
About Thomas Seeholzer
Thomas Seeholzer is a scholar working on Immunology, Molecular Biology, Cancer Research, Oncology and Molecular Medicine, having authored 18 papers that have together received 379 indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (6 papers), Antibiotic Resistance in Bacteria (4 papers), T-cell and B-cell Immunology (3 papers), Immune Response and Inflammation (2 papers), Antibiotic Use and Resistance (2 papers), Ubiquitin and proteasome pathways (2 papers), Immunotherapy and Immune Responses (2 papers) and interferon and immune responses (2 papers). The work is most often cited by research in Cancer Research (121 citations), Immunology (170 citations), Applied Microbiology and Biotechnology (7 citations), Molecular Medicine (18 citations) and Oncology (76 citations). Thomas Seeholzer has collaborated with scholars based in Germany, Ethiopia and United States. Frequent co-authors include Daniel Krappmann, Torben Gehring, Jürgen Ruland, Katja Lammens, Andreas Gewies, Thomas Brocker, Ute Greczmiel, Isabel Meininger, Florian Heyd and Karl‐Peter Hopfner. Their work appears in journals such as Frontiers in Immunology, Antibiotics, Nature Communications, Science Signaling and Journal of the European Academy of Dermatology and Venereology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.